Clinical Study
Impact of Benign Prostatic Hyperplasia Pharmacological Treatment on Transrectal Prostate Biopsy Adverse Effects
Table 1
Correlation between prostate biopsy adverse effects and pharmacological treatment for benign prostatic hyperplasia.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Control: patients not using any medication (control/reference). Group 1: patients using alpha-blockers, exclusively. Group 2: patients using 5-alpha-reductase, exclusively. Group 3: patients using both medications. value ≤0.05 was considered significant (bold).*Lasting more than one week after the procedure. **Visual analog scale (VAS) ≥5, 24 h after the procedure. |